Chemotherapy for bladder cancer.
D000287:Administration, Topical; D000477:Alkylating Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001772:Blood Cell Count; D002291:Carcinoma, Papillary / Q000188:drug therapy* / Q000601:surgery; D003556:Cystitis / Q000139:chemically induced; D003558:Cystoscopy; D004987:Ethers / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005009:Ethoglucid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy* / Q000601:surgery; D011182:Postoperative Care; D011300:Preoperative Care; D013852:Thiotepa / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000601:surgery; D014546:Urinary Catheterization; D014555:Urination Disorders / Q000139:chemically induced
D000477:Alkylating Agents; D004987:Ethers; D005009:Ethoglucid; D013852:Thiotepa